1 Erratum to: Clin Drug Investig (2010) 30(9):581–597 DOI 10.2165/11536710-000000000-00000
Page 587, Figure 2, right-hand side of the figure, third box from bottom, which previously read:
“OM/HCTZ 40 mg
n = 129”
should read:
“OM 40 mg
n = 129”
Page 587, Figure 2, right-hand side of the figure, first box from bottom, which previously read:
“Completed
OM/HCTZ 40 mg
n = 128”
should read:
“Completed
OM 40 mg
n = 128”
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.2165/11536710-000000000-00000.
Rights and permissions
About this article
Cite this article
Fogari, R., Taddei, S., Holm-Bentzen, M. et al. Erratum to: Efficacy and Safety of Olmesartan Medoxomil 40 mg/Hydrochlorothiazide 12.5 mg Combination Therapy versus Olmesartan Medoxomil 40 mg Monotherapy in Patients with Moderate to Severe Hypertension. Clinical Drug Investigation 33, 95 (2013). https://doi.org/10.1007/s40261-012-0048-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40261-012-0048-7